Centene Corporation’s CNC improving medical membership, growing top line, pursuit of buyouts, numerous contract wins and continued data-driven innovation make it worth retaining in one’s portfolio.

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, ...

Argus downgraded Centene (NYSE:CNC) to Hold from Buy on Thursday, citing the Medicaid-focused insurer’s recent Q4 2024 results and projecting an uncertain outlook for the company’s operations in ...

Centene Corporation CNC is expected to remain on its growth track with the help of increasing memberships and a strong focus on business streamlining. Nevertheless, weakness in Commercial business ...

Barclays analyst Andrew Mok CFA maintained a Hold rating on Centene today and set a price target of $33.00. The company’s shares closed yesterday at $31.06. Take advantage of TipRanks Premium at 50% ...

Mizuho Securities analyst Ann Hynes maintained a Hold rating on Centene (CNC – Research Report) on March 5 and set a price target of $71.00. See what stocks are receiving Strong Buy ratings from ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Hold rating on Centene, with a price target of $30.00. The company’s shares closed yesterday at $26.93. Take advantage of ...